Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis

Clinical Drug Investigation

Volumn 32, Issue 12, 2012, Pages 827-833

  Gallelli, L ^a   Galasso, O ^a   Urzino, A ^a   Sacca S ^a   Falcone, D ^a   Palleria, C ^a   Longo, P ^a   Corigliano, A ^a   Terracciano, R ^a   Savino, R ^a   Gasparini, G ^a   De Sarro, G ^a   Southworth, S R ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b PLLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; IBUPROFEN;

AGED; ANALGESIA; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG HYPERSENSITIVITY; DRUG SYNOVIAL FLUID LEVEL; EPIGASTRIC PAIN; FEMALE; HEALTH STATUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; KNEE OSTEOARTHRITIS; MALE; MASS FRAGMENTOGRAPHY; NAUSEA; PAIN ASSESSMENT; PHARMACOGENETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; TREATMENT OUTCOME;

EID: 84873471483     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.1007/s40261-012-0011-7     Document Type: Article

References (25)

1. Oliva F, Gallelli L. Ibuprofen pharmacology and its implications for musculoskeletal disorders. Funct Neurol. 2010;25:1-19.
2. Mariconda M, Galasso O, Costa GG, et al. Quality of life and functionality after total hip arthroplasty: a long-term follow-up study. BMC Musculoskelet Disord. 2011;12:222.
3. Rainsford KD. History and development of ibuprofen. In: Rainsford KD, editor. Ibuprofen. A Critical Bibliographic Review. London: Taylor & Francis; 1999. p. 3-24.
4. Fendrick M, Greenberg BP. A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis. Osteopath Med Prim Care. 2009;3:1-7.
5. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137-62.
6. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol. 1992;19:1950-4.
7. Seideman P, Lohrer F, Graham GG, Duncan MW, Williams KM, Day RO. The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid. Br J Clin Pharmacol. 1994;38:221-7.
8. Bradley JD, Rudy AC, Katz BP, et al. Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis. J Rheumatol. 1992;19:130-4.
9. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991;325(2):87-91.
10. Whitlam JB, Brown KF, Crooks MJ, Room GF. Transsynovial distribution of ibuprofen in arthritic patients. Clin Pharmacol Ther. 1981;29:487-92.
11. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of OA. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum. 1986;29:1039-49.
12. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494-502.
13. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-40.
14. Klassbo M, Larsson E, Mannevik E. Hip disability and osteoarthritis outcome score. An extension of the western Ontario and McMaster Universities osteoarthritis index. Scand J Rheumatol. 2003;32:46-51.
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.
16. World Health Organization. Uppsala monitoring left. Causality assessment of suspected adverse reactions (online). Available from URL http://who-umc.org/ Graphics/24734.pdf (2012). Accessed 1 Oct 2012.
17. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.
18. De Fazio S, Gallelli L, De Siena A, et al. Role of CYP3A5 in abnormal clearance of methadone. Ann Pharmacother. 2008;42:893-7.
19. Gallelli L, Colosimo M, Tolotta GA, et al. Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol. 2010;66:137-44.
20. Davies NM. Clinical pharmacokinetics of Ibuprofen. The first 30 years. Clin Pharmacokinet. 1998;34:101-54.
21. Bushra R, Nousheen A. An overview of clinical pharmacology of Ibuprofen. Oman Med J. 2010;49:1-14.
22. Southworth SR. The role of intravenous NSAIDS in the multimodal treatment of postoperative pain. In: Analgesics: new research. New York: NOVA Publishers, accepted for publication, first quarter 2012.
23. Boureau F, Schneid H, Zeghari N, et al. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip. Ann Rheum Dis. 2004;63:1028-34.
24. Schiff M, Minic M. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee. J Rheumatol. 2004;31:1373-83.
25. Gallelli L, Colosimo M, Pirritano D, et al. Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Invest. 2007;27:115-22.